Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine for myocardial stunning in STEMI
NCT05014061Phase 3Withdrawn
- Sponsor
- Region Västra Götaland
- Start
- Jan 2023
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of adenosine in ST elevation myocardial infarction (STEMI), sponsored by Region Västra Götaland. Planned start Jan 2023; status: withdrawn.
02
Drugs
adenosine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05014061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05014061.